Amgen’s Revenue Grows As It Awaits Phase III Data For Next Potential Blockbuster

Enrollment Complete In First Two MariTide Pivotal Trials

 
• By Mandy Jackson
  
Amgen gained more than 6% in after-hours trading on Nov. 4 after reporting Q3 earnings (Shutterstock)

More from Scrip

More from Earnings